KEY TOPICS TO BE ADDRESSED AT THIS CONFERENCE: -
鈥rinciples of Pharmacovigilance and Data Resources
鈥isk Management and Risk Minimisation
鈥ausality Assessment: Clinical Diagnosis of Adverse Events
鈥ASS and PAES studies
鈥egulatory Framework
鈥uropean Post-Marketing Pharmacovigilance Regulations
鈥harmacoepidemiological Studies
鈥volution of PSURs, PBRERs, DSURs
鈥ro-active Pharmacovigilance Pre- and Post-Marketing
鈥linical Trial ADR reporting requirements
鈥isk/Benefit Analysis
鈥rug Surveillance in countries outside Europe
鈥ost-marketing Surveillance: Observational Cohort Studies
鈥ntroduction to Signal detection
鈥ntroduction to Risk Management plans
鈥ractical Pharmacovigilance Workshop
鈥rinciples of Pharmacovigilance and Data Resources
鈥isk Management and Risk Minimisation
鈥ausality Assessment: Clinical Diagnosis of Adverse Events
鈥ASS and PAES studies
鈥egulatory Framework
鈥uropean Post-Marketing Pharmacovigilance Regulations
鈥harmacoepidemiological Studies
鈥volution of PSURs, PBRERs, DSURs
鈥ro-active Pharmacovigilance Pre- and Post-Marketing
鈥linical Trial ADR reporting requirements
鈥isk/Benefit Analysis
鈥rug Surveillance in countries outside Europe
鈥ost-marketing Surveillance: Observational Cohort Studies
鈥ntroduction to Signal detection
鈥ntroduction to Risk Management plans
鈥ractical Pharmacovigilance Workshop
